Clene Nanomedicine Presents New Neuroprotection Data in Parkinson's Disease with Lead Nanocatalytic Therapeutic, CNM-Au8
Clene Nanomedicine Presents New Neuroprotection Data in Parkinson's Disease with Lead Nanocatalytic Therapeutic, CNM-Au8
Although targeting Parkinson's, new product approved for consideration in Amyotrophic Lateral Sclerosis and other neurological disorders.